Administrative Measures on Filing for Medical Representatives

2020-10-10

On September 30, 2020, NMPA released the Administrative Measures on Filing for Medical Representatives (trial). A medical representative hereof refers to a professional who is engaged in the transmission, communication and feedback of pharmaceutical information in China on behalf of a pharmaceutical marketing license holder. This Measures is intended to standardize the practice of medical representatives so if this may impact your business in China, please email info@inspirativemed.com for more information.

Link: https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20200930163955170.html